Bright Minds Biosciences
(NASDAQ:DRUG)
$1.13
0.03[2.73%]
At close: Apr 26
$1.13
0[0.00%]
PreMarket: 5:36PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Bright Minds Biosciences Stock (NASDAQ:DRUG), Earnings Estimates, EPS, and Revenue

Bright Minds Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 13
EPS
$-0.440
Quarterly Revenue
$0K
Annual Revenue
(as of Dec 31)
–

Analyze the earnings history of Bright Minds Biosciences using advanced sorting and filters.

Date
▲▼
time
▲▼
ticker
▲▼
Quarter
▲▼
Prior EPS
▲▼
Est EPS
▲▼
Actual EPS
▲▼
EPS Surprise
▲▼
Prior Rev
▲▼
Est Rev
▲▼
Actual Rev
▲▼
Rev Surprise
▲▼
Get Alert
05/14/2024AMDRUGQ2————————Get Alert
02/13/2024PMDRUGQ1-$0.65—-$0.44—$0.00—$0.00—Get Alert

FAQ

Q

When is Bright Minds Biosciences (NASDAQ:DRUG) reporting earnings?

A

Bright Minds Biosciences (DRUG) is scheduled to report earnings on May 14, 2024. The last reported earnings were for reported on February 13, 2024 for Q1.

Q

What were the latest earnings per share (EPS) for Bright Minds Biosciences (NASDAQ:DRUG)?

A

The Actual EPS was $-0.44, which missed the estimate of $0.00.

Q

What were Bright Minds Biosciences’s (NASDAQ:DRUG) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.